COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
Suzanne C. Cannegieter, Frederikus A. Klok
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative pathogen of a new infectious disease, coronavirus disease 2019 (COVID‐19), that first occurred in late December 2019 in the city of Wuhan in Hubei Province, China. It has since spread globally, resulting in a World Health Organization (WHO) declared pandemic, with as yet (April 28, 2020) >3 million confirmed cases and >200 000 confirmed deaths. As for every new disease, clinicians, hospitals, and governments struggle to find optimal clinical and public health measures to contain its spread and burden.
Topics & Concepts
InterimPandemicCoronavirus disease 2019 (COVID-19)DiseaseMedicinePublic healthCoagulopathyInfectious disease (medical specialty)Intensive care medicineCoronavirus2019-20 coronavirus outbreakVirologyOutbreakInternal medicinePolitical sciencePathologyLawVenous Thromboembolism Diagnosis and ManagementCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts